Walter Cunningham

Walter Cunningham currently serves as a Territory Manager at Snap Diagnostics since October 2022. Prior to this role, Walter was a Respiratory Business Specialist at Boehringer Ingelheim from January 2018 to October 2022, where responsibilities included representing Stiolto Respimat and Spiriva Respimat for COPD and asthma treatment. Walter also contributed to the women's health sector by representing Sprout Pharmaceuticals during the launch of Addyi, an FDA-approved treatment for pre-menopausal women with Hypoactive Sexual Desire Disorder. Previously, Walter owned and operated BDW Sales from April 2007 to September 2015, handling various business operations across medical and scholastic industries. Earlier experience includes a Sales Representative position at Takeda Pharmaceuticals, where a successful launch of Rozerem for insomnia was achieved. Walter holds a Bachelor of Science in Business Administration from the University of Tennessee, Knoxville, and completed training at Aviation Officer Candidate School.